Stock listing

4588 Stock Price, News, Filings & Events — Oncolys Biopharma, Inc.

Selected listing: 4588 · TSE · JPY · JP

This page tracks Oncolys Biopharma, Inc.'s 4588:TSE listing on TSE in JPY for JP, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4588:TSE. 4588:TSE is the stock-level entry point for investors researching Oncolys Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Oncolys Biopharma, Inc. is a public company listed under the ticker 4588 in the Japanese market. The company has a market capitalization of approximately 455.27 million USD. Oncolys focuses on developing innovative biopharmaceuticals to address unmet medical needs.

4588:TSEJPYJPUpdated September 12, 2026
Oncolys Biopharma, Inc. logo
Ticker
4588:TSE
Asset type
Stock
Market cap
$1.10B
Sector
Health Technology
Industry
Biotechnology
Exchange
TSE
Currency
JPY

Oncolys Biopharma, Inc. 4588:TSE stock context

This page tracks Oncolys Biopharma, Inc.'s 4588:TSE listing on TSE in JPY for JP, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4588:TSE. 4588:TSE is the stock-level entry point for investors researching Oncolys Biopharma, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Oncolys Biopharma, Inc. is a public company listed under the ticker 4588 in the Japanese market. The company has a market capitalization of approximately 455.27 million USD. Oncolys focuses on developing innovative biopharmaceuticals to address unmet medical needs.

Latest news from Oncolys Biopharma, Inc.

All Oncolys Biopharma, Inc. news →

Research Oncolys Biopharma, Inc.